Video

Metastatic Gastric Cancer: Factors in Selecting Frontline Therapy

Author(s):

Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer CenterDaniel V. Catenacci, MD, University of Chicago

Transcript:

Related Videos
Daniel M. Halperin, MD, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Haeseong Park, MD, MPH
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO
Milind Javle, MD; and Rachna Shroff, MD, MS, FASCO
Milind Javle, MD, and Rachna Shroff, MD, MS, FASCO
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; Steven Scott West
Related Content
Arndt Vogel, MD
June 2nd 2024

First-Line Camrelizumab Plus Rivoceranib Maintains Survival Benefit in Unresectable HCC

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Jens Hoeppner, FAChirg, FACS, MD
June 2nd 2024

Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer

Gina Z. D’Amato, MD
February 9th 2023

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

Shadmehr Demehri, MD, PhD
May 30th 2024

Pitavastatin Offers Therapeutic Potential in Cancers Arising From Chronic Inflammation

OncLive On Air
May 30th 2024

Revisit Every OncLive On Air Episode From May 2024